Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-11-06 BALDO LANCE Chief Medical Officer Sale −797 $51.26 $41K 0
2020-11-06 BALDO LANCE Chief Medical Officer Option exercise · Stock Option (Right to Buy) −6,250 387,500
2020-11-06 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-11-06 ROBINS HARLAN S Chief Scientific Officer Sale −1,500 $50.48 $76K 10,279
2020-11-06 ROBINS HARLAN S Chief Scientific Officer Sale −8,700 $51.57 $449K 1,579
2020-11-06 ROBINS HARLAN S Chief Scientific Officer Sale −900 $52.50 $47K 679
2020-11-06 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 233,700
2020-11-05 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-11-05 ROBINS HARLAN S Chief Scientific Officer Sale −7,254 $50.00 $363K 4,525
2020-11-05 ROBINS HARLAN S Chief Scientific Officer Sale −3,846 $50.88 $196K 679
2020-11-05 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 244,800
2020-11-04 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 11,779
2020-11-04 ROBINS HARLAN S Chief Scientific Officer Sale −9,800 $50.20 $492K 1,979
2020-11-04 ROBINS HARLAN S Chief Scientific Officer Sale −1,300 $50.98 $66K 679
2020-11-04 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 255,900
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise +2,605 $6.55 $17K 2,605
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise +2,604 $6.55 $17K 5,209
2020-11-02 BENZENO SHARON Chief Business Development Off Option exercise +1,563 $7.27 $11K 6,772
2020-11-02 BENZENO SHARON Chief Business Development Off Sale −5,698 $45.47 $259K 1,074
2020-11-02 BENZENO SHARON Chief Business Development Off Sale −1,074 $46.14 $50K 0

Page 84 of 120 · 2,386 trades